By
Marianne Chang
Published: June 5, 2023, 8:32 p.m.·
Tags:
Vaccines
22 May 2023 -- Quratis said on Monday that the phase 2a clinical trial results of its novel tuberculosis (TB) vaccine for adults and adolescents, QTP101, showed excellent safety and immunogenicity.
Read More →